Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc., announced that it is developing new Quality Management solutions, in collaboration with Accuray, for the...
Accuray Incorporated announced that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery hypofractionated radiotherapy delivered with the TomoTherapy® System is superior...
